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INTRODUCTION
Seborrheic dermatitis is a chronic papulo-
squamous disorder affecting the sebum-rich areas of 
the scalp, face and trunk, commonly aggravated by 
factors like changes in season and humidity, trauma, 
emotional stress, and alcohol consumption. The 
Address for correspondence: 
Jenya Dimitrova, MD
Department of Dermatology and Venerology, 
Medical University of Varna 
55 Marin Drinov Str., 9002 Varna, Bulgaria
E-mail: dimitrova_derm@abv.bg 
Phone: +359889706042
prevalence rate of seborrheic dermatitis is 3-5% (6) 
with worldwide distribution. The mildest form of 
seborrheic dermatitis, i.e. dandruff, is much more 
common and affects 15-20% of the population.
The etiology and pathogenesis of seborrheic 
dermatitis is not elucidated yet. While in the past 
Malassezia species were thought to be the main 
pathogenic factor, now it is considered that Malassezia 
levels may be normal but there is an abnormal 
immune response and, probably, skin-barrier 
dysfunction in subjects prone to this dermatitis 
(13,15). T-helper cells, phytohemagglutinin and 
concavalin stimulation as well as antibody titres 
are reduiced in patients with seborrheic dermatitis 
compared with those of control subjects.
ABSTRACT
PURPOSE: Seborrheic dermatitis is papulo-squamous disorder affecting 3-5% of the population. Its patho-
genesis is not elucidated yet. The purpose of our study was to find out the serum level of 25-hydroxyvitamin 
D (25-(OH) vit. D) in patients with clinicaly manifested seborrheic dermatitis.
MATERIAL AND METHODS: Twenty-two patients, 11 females and 11males, were examined for serum 25-
(OH) vit. D. One patient was at remission stage. The values were measured by means of electrochemilumi-
nescence immunoassay analyzer. The study was carried out between November and August. 
RESULTS: During the whole period of the study none of the patients showed optimal level of serum 25-(OH) 
vit D. Three patients presented with suboptimal values of 25-(OH) vit. D (13,6% of the cases). The rest 19 pa-
tients (86,3%) showed insufficiency of 25-(OH) vit. D with values under 30 ng/mL and 13 of them (68,4%) 
were with pronounced deficiency - serum 25-(OH) vit. D under 20 ng/mL. Only two patients (10,5%) present-
ed with a severe deficiency and value of 25-(OH) vit. D under 10 ng/mL. 
CONCLUSION: We could conclude that the patients with exacerbated seborrheic dermatitis present with 
25-(OH) vit. D insufficiency and deficiency. Our results allow us to suggest that vit. D may play a role in the 
pathogenesis of seborrheic dermatitis. Consequently, its supplementation may be used in the treatment of 
this pathology. To our knowledge, this is the first study of serum 25-(OH) vit. D levels in patients with seb-
orrheic dermatitis and these results promise multiple directions for further research. 
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The spontaneous remission of seborrheic 
dermatitis in summer and the therapeutic effect of 
vit. D in other papulo-squamous dermatosis such 
as psoriasis (1,7,9) suggested us to study vit. D status 
of patients with seborrheic dermatitis. Even more, 
recent studies demonstrate that keratinocytes possess 
vit. D receptors which inhibit the proliferation 
and stimulate the differentiation of the epidermal 
cells (4,5,11). Vit. D receptor ligands diminish the 
expression level of proinflamatory cytokines (8,12,16) 
and exert therapeutic effect in many autoimmune 
and skin diseases (10).
The objective of the present study was to 
determine the serum level of 25-hydroxyvitamin D 
(25-(OH) vit. D) in patients with clinicaly manifested 
seborrheic dermatitis.
MATERIAL AND METHODS
Twenty-two seborrheic dermatitis patients, 11 
females and 11males, were examined for serum 25-
(OH) vit. D as the best indicator of vit. D status (17). 
These patients were aged between 5 and 61 years. 
With the exception of one male patient who was in 
remission in the time of testing the other patients 
presented with exacerbated dermatitis. Only one 
patient had flexural eruption. In the rest patients, 
scalp and face were affected. The patients were 
examined in the period from November to August 
in order to avoid the seasonal factor influencing 
on serum vit. D level. The latter was assessed by 
electrochemiluminescence immunoassay (ECLIA) 
method. 
As nowadays there is no standard definition of 
optimal vit. D status, the scale used here was that one 
recommended by the manufacturer of the ECLIA 
analyzer. According to this scale, preferred level of 
serum 25-(OH) vit. D is 30-70 ng/mL. The value of 
21-29 ng/mL is interpreted as insufficiency and the 
level under 20 ng/mL as deficiency. Serum 25-(OH) 
vit. D levels under 10 ng/mL are evaluated as a severe 
deficiency (2,3). 
RESULTS
During the whole period of the study none of 
the patients showed optimal level of serum 25-(OH) 
vit D. Three patients presented with suboptimal 
values of 25-(OH) vit. D (13,6% of the cases). These 
patients were male, one of them was the patient who 
was at remission stage during the blood examination. 
Interestingly, the values of those three patients were 
all near the lower limit of the reference interval, i. e. 
30,03; 34,40 and 33,79 ng/mL, respectively.
The rest 19 patients (86,3%) showed 
insufficiency of 25-(OH) vit. D with values under 
30 ng/mL. Four patients (21%) showed results 
between 21-29 ng/mL and 13 ones (68,4%) were with 
pronounced deficiency - serum 25-(OH) vit. D under 
20 ng/mL. Only two patients (10,5%) presented with 
a severe deficiency and value of 25-(OH) vit. D under 
10 ng/mL. Only two patients (10,5%) presented with 
a severe deficiency and value of 25-(OH) vit. D under 
10 ng/mL. One of them was a 5-year old girl with 
scalp and flexural eruption. The other patient was a 
18-year old female with seborrheic dermatitis of the 
scalp that was recalcitrant to antifungal treatment.
Patients’ distribution according to age and 25-
(OH) vit. D value indicated similar gender patterns. 
Deficiency was 31, 6% and insufficiency was 10,5% in 
males, i.e. comparable to 36,6% and 10,5% in females, 
respectively (Table 1).
When the patients with 25-(OH) vit. D deficiency 
(with values under 20 ng/mL) were stratified by age 
it became obvious that in males, seborreic dermatitis 
was more common in the age group of 30-40 years. 
On the other hand, females aged 10-20 years showed 
the highest percentage (44%) followed by those aged 
20-30 and 51-60 years - 22% each (Table 2).
DISCUSSION
In the last few years, vit. D is widely 
investigated because of the fact that except its role 




n % n %
29-21 ng/mL 2 10,5 2 10,5
20-10 ng/mL 6 31,6 7 36,8
<10 ng/mL 0 0 2 10,5
Table 1. Gender distribution of the patients with serum 
25-hydroxyvitamin D insufficiency (<30 ng/mL)
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prodifferentiative and immunomodulatory 
activities (4,8,11,14). Vit. D receptors are established 
in keratinocytes where they exert an effect on 
proliferation and differentiation of epidermal cells 
(5). Vit. D deficiency in patients with seborrheic 
dermatitis established by us and the well-known 
therapeutic effect of this vitamin in the other papulo-
squamous disorder, psoriasis vulgaris, allow us to 
believe that its supplementation may have therapeutic 
effect in seborrheic dermatitis, too. In addition, vit. 
D deficiency in patients with seborrheic dermatitis 
despite the seasonal factor necessiates additional 
studies of vit. D synthesis in such patients.
CONCLUSION
We could draw the conclusion thatat despite 
the season, the patients with exacerbated seborrheic 
dermatitis present with 25-(OH) vit. D insufficiency 
and deficiency. The absence of optimal vit. D status 
in such patients suggests a pathogenetic role of this 
vitamin. This conclusion is concordant with the 
well-known fact that seborrheic dermatitis patients 
experience a significant alleviation of the disease 
during summer. Consequently, its supplementation 
may be used in the treatment of this pathology. To our 
knowledge, this is the first study of serum 25-(OH) 
vit. D levels in patients with seborrheic dermatitis 
and these results promise multiple directions for 
further research. 
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